Articles

Nov 13, 2025

Where Venture Alpha Goes Next India’s Model of Disciplined Growth and Realised Returns By Harry Paul — Managing Partner, Access India Ventures

As venture capital recalibrates globally, the model that once defined success in Silicon Valley is showing strain. This essay explores why India’s disciplined, capital-efficient ecosystem may define the next decade of sustainable venture returns.

 

The End of an Era of Abundance

For forty years, venture capitalists have looked west for inspiration and returns. Silicon Valley built the modern template for financing innovation: a self-reinforcing ecosystem of capital, talent, and ambition that reshaped industries from computing to biotechnology. Its success became the global benchmark for how ideas turn into enterprises.

 

Yet success breeds maturity, and what was once frontier is now establishment. The Valley remains an extraordinary source of invention, and influence, but as an investment system one could argue that it has aged. Capital is plentiful, competition relentless, and inefficiency - the raw material of venture alpha - has been eliminated through competition.

 

Valuations expanded through years of cheap money, and when interest rates rose, the system faltered. In 2021, global venture investment peaked at roughly US $640 billion; by 2023 it had fallen by more than half. Public-market exits dried up, median Series B valuations in the United States dropped by over fifty per cent, and what had once felt like a perpetual motion machine began to slow.

 

When the Venture Model Stalls

The numbers tell a story of concentration and fatigue. Research by Cambridge Associates shows that nearly two-thirds of all venture profits in the United States accrued to fewer than five per cent of funds. The rest delivered returns barely above public-market benchmarks.

 

For many limited partners, the arithmetic has changed: longer hold periods, slower distributions, and a growing sense that the golden geography of venture is becoming a victim of its own success.

 

Investors are now returning to first principles. They seek capital efficiency, clearer governance, and faster routes to liquidity. In short, they want venture capital to behave as it was originally conceived: disciplined, data-driven, and aligned with realised value. That rediscovery of discipline is where India’s story begins.

 

India and the Discipline of Constraint

India’s entrepreneurs have built within constraint from the outset. They have learned to innovate where resources are limited, to measure progress by efficiency rather than expenditure, and to balance ambition with affordability.

 

The country’s venture ecosystem has grown up on lean capital: founders often reach product-market fit with less than US $5 million of investment, and early-stage valuations rarely exceed US $30 million. These fundamentals, which were once seen as limitations, now look like advantages.

 

According to Bain & Company’s India Venture Capital Report 2025, venture funding in India rose by 43 % in 2024 to US $13.7 billion, while deal volumes increased by 45 % to 1,270. Early- and mid-stage rounds made up more than ninety per cent of the market, a sign of genuine entrepreneurial depth rather than financial engineering.

 

Exits, long the weak point in the narrative, are improving. Bain notes that Indian venture and growth investors realised US $6.6 billion in 2023, a seventy-per-cent increase over the previous year, driven by secondary sales, strategic acquisitions, and a growing number of SME-exchange listings. Liquidity that has become scarce in the West is deepening in India.

 

Efficiency, Scale, and the Logic of Scarcity

Every venture cycle depends on inefficiency and the gap between potential and execution. Where systems are too efficient, alpha disappears. India’s inefficiencies, its fragmented markets, its infrastructure gaps, its local complexity, have become its opportunity.

 

Bain and HealthQuad estimate that India’s healthcare-innovation economy already exceeds US $30 billion and will double to US $60 billion by 2028, much of it built on modest seed rounds. With more than 600 million people under thirty-five, domestic demand is surging. Healthcare spending is growing at roughly 12% CAGR, and food demand is projected to rise by 70% by 2030, according to the FAO and IBEF.

 

Beneath this sits India’s digital public infrastructure: Aadhaar for identity, UPI for payments, ONDC for commerce, and the National Digital Health Mission. These open systems allow private innovation to scale quickly and cheaply. UPI alone processed more than 120 billion transactions in 2023, worth around US $2 trillion.

 

The companies emerging from this environment reflect its pragmatism. Qure.ai applies artificial intelligence to diagnose tuberculosis across India and Africa. DeHaat connects 1.8 million farmers to markets, credit, and inputs. What Silicon Valley builds for abundance, India builds for scarcity—and that makes it globally relevant.

 

Returns That Reward Discipline

Over the past decade, top-quartile Indian early-stage funds have delivered 20–25%net IRR, comparable to leading U.S. peers, but achieved through lower entry valuations, shorter holding periods, and earlier liquidity. Bain estimates that leading Indian early-stage funds are already delivering DPI of 0.35–0.5× within five years, compared with 0.25–0.3× for global peers.

 

These returns are not the product of exuberance but of structure: rational pricing, disciplined ownership, and efficiency that converts capital into realised value. For investors, India offers equivalent performance, realised sooner, with less capital at risk.

 

Balancing Risk and Reform

No market is without risk. India still contends with regulatory complexity, currency volatility, and uneven liquidity, yet all are improving. SEBI’s alternative-investment and offshore-listing reforms have added transparency, more than 250 companies have listed on SME exchanges since 2020, and domestic M&A volumes are rising. The rupee has traded within a narrow band for several years, adding macro stability to a story of micro-opportunity. For international investors partnering with experienced local managers, these are manageable risks rather than structural barriers.

 

From Strain to Opportunity

The global venture industry is evolving from exuberance to discipline. The correction that unsettled Silicon Valley is, in India, an affirmation of its strengths. What others see as constraint - lean capital, pragmatic growth, and cautious valuation - is in fact the architecture of resilience.

 

India now offers the same potential returns as mature markets but with better capital efficiency, shorter holding periods, and earlier liquidity. For many LPs, the question is no longer whether India belongs in a portfolio, but whether a venture allocation is complete without it.

 

The LP Perspective

Allocating to India is not simply diversification, it is participation in a new cycle of disciplined venture growth. This is a market where scarcity drives innovation, where capital efficiency converts to realised value, and where the pursuit of alpha is grounded in fundamentals rather than fashion.

 

The next decade of venture outperformance will belong to funds that mastered efficiency before abundance returns. In a world relearning the value of discipline, India is where venture’s next generation of alpha will be built.

 

#AccessIndiaVentures #VentureCapital #HealthTech #AgriTech #IndiaGrowthStory #EmergingMarkets #LPInsights #SustainableAlpha

 

 

 

References

1.              Bain & Company (2025). India Venture Capital Report 2025.
Key data on 2024 funding volumes, exit values, and Asia-Pacific share of VC investment.

2.              Bain & Company and HealthQuad (2024). Healthcare Innovation in India Report.
Market size and growth projections for India’s healthtech sector (US $30B–$60B by 2028).

3.              Cambridge Associates (2023). Venture Capital Index and Selected Benchmark Statistics.
Long-term IRR data and fund concentration analysis for U.S. and global venture funds.

4.              Preqin (2024). Asia-Pacific Private Capital Performance Overview.
Comparative returns for Indian and Asia-Pacific early-stage venture funds.

5.              Food and Agriculture Organization (FAO) and India Brand Equity Foundation (IBEF) (2024).
Consumption and food-demand growth projections for India to 2030.

6.              Reserve Bank of India (RBI) and National Payments Corporation of India (NPCI) (2024).
UPI transaction data for 2023, exceeding 120 billion transactions valued at US $2 trillion.

7.              Securities and Exchange Board of India (SEBI) (2024).
Alternative Investment Fund (AIF) and SME Listing updates; cumulative SME listings exceeding 250 since 2020.

Nov 13, 2025

Where Venture Alpha Goes Next India’s Model of Disciplined Growth and Realised Returns By Harry Paul — Managing Partner, Access India Ventures

As venture capital recalibrates globally, the model that once defined success in Silicon Valley is showing strain. This essay explores why India’s disciplined, capital-efficient ecosystem may define the next decade of sustainable venture returns.

 

The End of an Era of Abundance

For forty years, venture capitalists have looked west for inspiration and returns. Silicon Valley built the modern template for financing innovation: a self-reinforcing ecosystem of capital, talent, and ambition that reshaped industries from computing to biotechnology. Its success became the global benchmark for how ideas turn into enterprises.

 

Yet success breeds maturity, and what was once frontier is now establishment. The Valley remains an extraordinary source of invention, and influence, but as an investment system one could argue that it has aged. Capital is plentiful, competition relentless, and inefficiency - the raw material of venture alpha - has been eliminated through competition.

 

Valuations expanded through years of cheap money, and when interest rates rose, the system faltered. In 2021, global venture investment peaked at roughly US $640 billion; by 2023 it had fallen by more than half. Public-market exits dried up, median Series B valuations in the United States dropped by over fifty per cent, and what had once felt like a perpetual motion machine began to slow.

 

When the Venture Model Stalls

The numbers tell a story of concentration and fatigue. Research by Cambridge Associates shows that nearly two-thirds of all venture profits in the United States accrued to fewer than five per cent of funds. The rest delivered returns barely above public-market benchmarks.

 

For many limited partners, the arithmetic has changed: longer hold periods, slower distributions, and a growing sense that the golden geography of venture is becoming a victim of its own success.

 

Investors are now returning to first principles. They seek capital efficiency, clearer governance, and faster routes to liquidity. In short, they want venture capital to behave as it was originally conceived: disciplined, data-driven, and aligned with realised value. That rediscovery of discipline is where India’s story begins.

 

India and the Discipline of Constraint

India’s entrepreneurs have built within constraint from the outset. They have learned to innovate where resources are limited, to measure progress by efficiency rather than expenditure, and to balance ambition with affordability.

 

The country’s venture ecosystem has grown up on lean capital: founders often reach product-market fit with less than US $5 million of investment, and early-stage valuations rarely exceed US $30 million. These fundamentals, which were once seen as limitations, now look like advantages.

 

According to Bain & Company’s India Venture Capital Report 2025, venture funding in India rose by 43 % in 2024 to US $13.7 billion, while deal volumes increased by 45 % to 1,270. Early- and mid-stage rounds made up more than ninety per cent of the market, a sign of genuine entrepreneurial depth rather than financial engineering.

 

Exits, long the weak point in the narrative, are improving. Bain notes that Indian venture and growth investors realised US $6.6 billion in 2023, a seventy-per-cent increase over the previous year, driven by secondary sales, strategic acquisitions, and a growing number of SME-exchange listings. Liquidity that has become scarce in the West is deepening in India.

 

Efficiency, Scale, and the Logic of Scarcity

Every venture cycle depends on inefficiency and the gap between potential and execution. Where systems are too efficient, alpha disappears. India’s inefficiencies, its fragmented markets, its infrastructure gaps, its local complexity, have become its opportunity.

 

Bain and HealthQuad estimate that India’s healthcare-innovation economy already exceeds US $30 billion and will double to US $60 billion by 2028, much of it built on modest seed rounds. With more than 600 million people under thirty-five, domestic demand is surging. Healthcare spending is growing at roughly 12% CAGR, and food demand is projected to rise by 70% by 2030, according to the FAO and IBEF.

 

Beneath this sits India’s digital public infrastructure: Aadhaar for identity, UPI for payments, ONDC for commerce, and the National Digital Health Mission. These open systems allow private innovation to scale quickly and cheaply. UPI alone processed more than 120 billion transactions in 2023, worth around US $2 trillion.

 

The companies emerging from this environment reflect its pragmatism. Qure.ai applies artificial intelligence to diagnose tuberculosis across India and Africa. DeHaat connects 1.8 million farmers to markets, credit, and inputs. What Silicon Valley builds for abundance, India builds for scarcity—and that makes it globally relevant.

 

Returns That Reward Discipline

Over the past decade, top-quartile Indian early-stage funds have delivered 20–25%net IRR, comparable to leading U.S. peers, but achieved through lower entry valuations, shorter holding periods, and earlier liquidity. Bain estimates that leading Indian early-stage funds are already delivering DPI of 0.35–0.5× within five years, compared with 0.25–0.3× for global peers.

 

These returns are not the product of exuberance but of structure: rational pricing, disciplined ownership, and efficiency that converts capital into realised value. For investors, India offers equivalent performance, realised sooner, with less capital at risk.

 

Balancing Risk and Reform

No market is without risk. India still contends with regulatory complexity, currency volatility, and uneven liquidity, yet all are improving. SEBI’s alternative-investment and offshore-listing reforms have added transparency, more than 250 companies have listed on SME exchanges since 2020, and domestic M&A volumes are rising. The rupee has traded within a narrow band for several years, adding macro stability to a story of micro-opportunity. For international investors partnering with experienced local managers, these are manageable risks rather than structural barriers.

 

From Strain to Opportunity

The global venture industry is evolving from exuberance to discipline. The correction that unsettled Silicon Valley is, in India, an affirmation of its strengths. What others see as constraint - lean capital, pragmatic growth, and cautious valuation - is in fact the architecture of resilience.

 

India now offers the same potential returns as mature markets but with better capital efficiency, shorter holding periods, and earlier liquidity. For many LPs, the question is no longer whether India belongs in a portfolio, but whether a venture allocation is complete without it.

 

The LP Perspective

Allocating to India is not simply diversification, it is participation in a new cycle of disciplined venture growth. This is a market where scarcity drives innovation, where capital efficiency converts to realised value, and where the pursuit of alpha is grounded in fundamentals rather than fashion.

 

The next decade of venture outperformance will belong to funds that mastered efficiency before abundance returns. In a world relearning the value of discipline, India is where venture’s next generation of alpha will be built.

 

#AccessIndiaVentures #VentureCapital #HealthTech #AgriTech #IndiaGrowthStory #EmergingMarkets #LPInsights #SustainableAlpha

 

 

 

References

1.              Bain & Company (2025). India Venture Capital Report 2025.
Key data on 2024 funding volumes, exit values, and Asia-Pacific share of VC investment.

2.              Bain & Company and HealthQuad (2024). Healthcare Innovation in India Report.
Market size and growth projections for India’s healthtech sector (US $30B–$60B by 2028).

3.              Cambridge Associates (2023). Venture Capital Index and Selected Benchmark Statistics.
Long-term IRR data and fund concentration analysis for U.S. and global venture funds.

4.              Preqin (2024). Asia-Pacific Private Capital Performance Overview.
Comparative returns for Indian and Asia-Pacific early-stage venture funds.

5.              Food and Agriculture Organization (FAO) and India Brand Equity Foundation (IBEF) (2024).
Consumption and food-demand growth projections for India to 2030.

6.              Reserve Bank of India (RBI) and National Payments Corporation of India (NPCI) (2024).
UPI transaction data for 2023, exceeding 120 billion transactions valued at US $2 trillion.

7.              Securities and Exchange Board of India (SEBI) (2024).
Alternative Investment Fund (AIF) and SME Listing updates; cumulative SME listings exceeding 250 since 2020.

Nov 13, 2025

Where Venture Alpha Goes Next India’s Model of Disciplined Growth and Realised Returns By Harry Paul — Managing Partner, Access India Ventures

As venture capital recalibrates globally, the model that once defined success in Silicon Valley is showing strain. This essay explores why India’s disciplined, capital-efficient ecosystem may define the next decade of sustainable venture returns.

 

The End of an Era of Abundance

For forty years, venture capitalists have looked west for inspiration and returns. Silicon Valley built the modern template for financing innovation: a self-reinforcing ecosystem of capital, talent, and ambition that reshaped industries from computing to biotechnology. Its success became the global benchmark for how ideas turn into enterprises.

 

Yet success breeds maturity, and what was once frontier is now establishment. The Valley remains an extraordinary source of invention, and influence, but as an investment system one could argue that it has aged. Capital is plentiful, competition relentless, and inefficiency - the raw material of venture alpha - has been eliminated through competition.

 

Valuations expanded through years of cheap money, and when interest rates rose, the system faltered. In 2021, global venture investment peaked at roughly US $640 billion; by 2023 it had fallen by more than half. Public-market exits dried up, median Series B valuations in the United States dropped by over fifty per cent, and what had once felt like a perpetual motion machine began to slow.

 

When the Venture Model Stalls

The numbers tell a story of concentration and fatigue. Research by Cambridge Associates shows that nearly two-thirds of all venture profits in the United States accrued to fewer than five per cent of funds. The rest delivered returns barely above public-market benchmarks.

 

For many limited partners, the arithmetic has changed: longer hold periods, slower distributions, and a growing sense that the golden geography of venture is becoming a victim of its own success.

 

Investors are now returning to first principles. They seek capital efficiency, clearer governance, and faster routes to liquidity. In short, they want venture capital to behave as it was originally conceived: disciplined, data-driven, and aligned with realised value. That rediscovery of discipline is where India’s story begins.

 

India and the Discipline of Constraint

India’s entrepreneurs have built within constraint from the outset. They have learned to innovate where resources are limited, to measure progress by efficiency rather than expenditure, and to balance ambition with affordability.

 

The country’s venture ecosystem has grown up on lean capital: founders often reach product-market fit with less than US $5 million of investment, and early-stage valuations rarely exceed US $30 million. These fundamentals, which were once seen as limitations, now look like advantages.

 

According to Bain & Company’s India Venture Capital Report 2025, venture funding in India rose by 43 % in 2024 to US $13.7 billion, while deal volumes increased by 45 % to 1,270. Early- and mid-stage rounds made up more than ninety per cent of the market, a sign of genuine entrepreneurial depth rather than financial engineering.

 

Exits, long the weak point in the narrative, are improving. Bain notes that Indian venture and growth investors realised US $6.6 billion in 2023, a seventy-per-cent increase over the previous year, driven by secondary sales, strategic acquisitions, and a growing number of SME-exchange listings. Liquidity that has become scarce in the West is deepening in India.

 

Efficiency, Scale, and the Logic of Scarcity

Every venture cycle depends on inefficiency and the gap between potential and execution. Where systems are too efficient, alpha disappears. India’s inefficiencies, its fragmented markets, its infrastructure gaps, its local complexity, have become its opportunity.

 

Bain and HealthQuad estimate that India’s healthcare-innovation economy already exceeds US $30 billion and will double to US $60 billion by 2028, much of it built on modest seed rounds. With more than 600 million people under thirty-five, domestic demand is surging. Healthcare spending is growing at roughly 12% CAGR, and food demand is projected to rise by 70% by 2030, according to the FAO and IBEF.

 

Beneath this sits India’s digital public infrastructure: Aadhaar for identity, UPI for payments, ONDC for commerce, and the National Digital Health Mission. These open systems allow private innovation to scale quickly and cheaply. UPI alone processed more than 120 billion transactions in 2023, worth around US $2 trillion.

 

The companies emerging from this environment reflect its pragmatism. Qure.ai applies artificial intelligence to diagnose tuberculosis across India and Africa. DeHaat connects 1.8 million farmers to markets, credit, and inputs. What Silicon Valley builds for abundance, India builds for scarcity—and that makes it globally relevant.

 

Returns That Reward Discipline

Over the past decade, top-quartile Indian early-stage funds have delivered 20–25%net IRR, comparable to leading U.S. peers, but achieved through lower entry valuations, shorter holding periods, and earlier liquidity. Bain estimates that leading Indian early-stage funds are already delivering DPI of 0.35–0.5× within five years, compared with 0.25–0.3× for global peers.

 

These returns are not the product of exuberance but of structure: rational pricing, disciplined ownership, and efficiency that converts capital into realised value. For investors, India offers equivalent performance, realised sooner, with less capital at risk.

 

Balancing Risk and Reform

No market is without risk. India still contends with regulatory complexity, currency volatility, and uneven liquidity, yet all are improving. SEBI’s alternative-investment and offshore-listing reforms have added transparency, more than 250 companies have listed on SME exchanges since 2020, and domestic M&A volumes are rising. The rupee has traded within a narrow band for several years, adding macro stability to a story of micro-opportunity. For international investors partnering with experienced local managers, these are manageable risks rather than structural barriers.

 

From Strain to Opportunity

The global venture industry is evolving from exuberance to discipline. The correction that unsettled Silicon Valley is, in India, an affirmation of its strengths. What others see as constraint - lean capital, pragmatic growth, and cautious valuation - is in fact the architecture of resilience.

 

India now offers the same potential returns as mature markets but with better capital efficiency, shorter holding periods, and earlier liquidity. For many LPs, the question is no longer whether India belongs in a portfolio, but whether a venture allocation is complete without it.

 

The LP Perspective

Allocating to India is not simply diversification, it is participation in a new cycle of disciplined venture growth. This is a market where scarcity drives innovation, where capital efficiency converts to realised value, and where the pursuit of alpha is grounded in fundamentals rather than fashion.

 

The next decade of venture outperformance will belong to funds that mastered efficiency before abundance returns. In a world relearning the value of discipline, India is where venture’s next generation of alpha will be built.

 

#AccessIndiaVentures #VentureCapital #HealthTech #AgriTech #IndiaGrowthStory #EmergingMarkets #LPInsights #SustainableAlpha

 

 

 

References

1.              Bain & Company (2025). India Venture Capital Report 2025.
Key data on 2024 funding volumes, exit values, and Asia-Pacific share of VC investment.

2.              Bain & Company and HealthQuad (2024). Healthcare Innovation in India Report.
Market size and growth projections for India’s healthtech sector (US $30B–$60B by 2028).

3.              Cambridge Associates (2023). Venture Capital Index and Selected Benchmark Statistics.
Long-term IRR data and fund concentration analysis for U.S. and global venture funds.

4.              Preqin (2024). Asia-Pacific Private Capital Performance Overview.
Comparative returns for Indian and Asia-Pacific early-stage venture funds.

5.              Food and Agriculture Organization (FAO) and India Brand Equity Foundation (IBEF) (2024).
Consumption and food-demand growth projections for India to 2030.

6.              Reserve Bank of India (RBI) and National Payments Corporation of India (NPCI) (2024).
UPI transaction data for 2023, exceeding 120 billion transactions valued at US $2 trillion.

7.              Securities and Exchange Board of India (SEBI) (2024).
Alternative Investment Fund (AIF) and SME Listing updates; cumulative SME listings exceeding 250 since 2020.

logo

Transforming India's Tomorrow: Investing in Healthtech, Agritech, and Emerging Technologies

logo

Transforming India's Tomorrow: Investing in Healthtech, Agritech, and Emerging Technologies

logo

Transforming India's Tomorrow: Investing in Healthtech, Agritech, and Emerging Technologies

© 2025 Access India Ventures

Made by Just

© 2025 Access India Ventures

Made by Just

© 2025 Access India Ventures

Made by Just